63 patents
Page 4 of 4
Utility
Compositions comprising an anti-C5 antibody
18 Nov 19
The present application relates to methods and compositions employing an antibody that inhibits activation of the complement system and can be used to prevent or treat a pulmonary disease or condition.
Yi Wang
Filed: 3 Oct 18
Utility
Treating seizure with recombinant alkaline phosphatase
21 Oct 19
The present disclosure provides a method of treating seizure in a subject having aberrant alkaline phosphatase activities, comprising administering a therapeutically effective amount of at least one recombinant alkaline phosphatase to the subject.
Andre Marozsan, Denise Devore, Susan Liu-Chen
Filed: 3 Dec 15
Utility
Anti-C5a antibodies
21 Oct 19
The present disclosure relates to, inter alia, antibodies, or antigen-binding fragments thereof, that bind to C5a and to use of the antibodies in methods for treating or preventing complement-associated disorders such as, but not limited to, atypical hemolytic uremic syndrome, age-related macular degeneration, rheumatoid arthritis, sepsis, severe burn, antiphospho lipid syndrome, asthma, lupus nephritis, Goodpasture's syndrome, and chronic obstructive pulmonary disease.
Russell P. Rother, Douglas L. Sheridan, Paul P. Tamburini, Yuchun Zhang
Filed: 28 Mar 18